Purchase of Pieffe Group, combined with new facility launches, brings UPS capacity nearly to 5 million sq.ft. worldwide; more expected in 2012
Every three months or so, UPS Healthcare Logistics, a dedicated unit of Big Brown for pharma, med devices and other healthcare products, announces the opening of a new distribution center or transportation hub; now it is growing by acquisition as well. The company announced the purchase of Pieffe Group, a mid-size distributor in Italy (with blue-chip clients like Pfizer, GSK, Novartis, Lilly and others), and two locations (Formello and Liscate). UPS has two other facilities in Italy, near Milan and Rome.
Bill Hook, president of UPS Healthcare Logistics, says that the company’s longterm strategy is to build or acquire resources globally commensurate with the global scale of its life sciences customers. “The Pieffe acquisition fits with our plans to expand in Europe, but more importantly, Pieffe brings the same cultural values of quality, service and regulatory compliance that we strive to maintain.” Pieffe’s existing services, beyond basic distribution, include labeling, controlled substances distribution, and temperature-sensitive handling.
UPS has opened new facilities in Venlo, the Netherlands, this year, which Hook says will be the hub for European distribution. In addition, new facilities have been opened in Brazil; Singapore; Louisville, KY; and Canada. “Going forward, we’re looking at China, Central America and Eastern Europe,” says Hook.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.